2022年8月12日

披露:帕特尔报告接受赠款资金从拜耳,飞利浦Respironics, Respicardia Sommetrics;顾问费用从拜耳和鲍威尔曼斯菲尔德;并担任顾问委员会和飞利浦Respironics NovaResp技术。请参阅研究对于所有其他作者的相关财务信息披露。主题添加到邮件提醒收到一封电子邮件在发布新文章时请提供您的电子邮件地址来接收电子邮件当张贴新文章。请稍后再试。如果你继续这个问题请联系customerservice@slackinc.com。回到Healio 3个月远程控制和指导项目导致立即短期CPAP依从性的改善,但未能导致持续的改善随着时间的推移,研究人员报道。”几项研究已经证明持续行为干预的好处,基于动机性访谈的概念发表了超过3个月没有这样的干预,”桑贾伊·r·帕特尔,医学博士,女士教授医学、流行病学、临床与转化科学和睡眠中心主任和心血管结果匹兹堡大学医疗中心的研究,和他的同事在美国胸科学会上写道。“然而,证据的优越性持续行为干预在一个有时限的CPAP依从性是有限的。”来源:Adobe股票。 Researchers assessed real-world CPAP adherence data from 26,489 patients who initiated CPAP from July 2018 to March 2020 (mean age, 55 years; 36% women). All participants utilized a 12-month commercially available telemonitoring and coaching program (Philips Respironics). The researchers compared those received 12 months (n = 3,264) or 3 months (n = 15,424) of support with those initiated CPAP without any support (n = 7,801). Overall nightly CPAP use declined from 4.9 hours at 1 month to 4.5 hours at 3 months, 4 hours at 6 months, 3.6 hours at 12 months and 3.2 hours at 18 months. Mean CPAP use differed slightly in the first month, at 5 hours of use for patients who received 12 months of support, 4.9 hours for patients who received 3 months of CPAP and 4.8 hours for patients who did not receive support. Patients who received 3 months of support had greater CPAP use compared with patients who received no support (4.6 vs. 4.3 hours; P < .001). However, by 12 and 18 months, CPAP use declined to match that of patients who received no support. Patients who received 12 months of support had greater CPAP use compared with those who received no support at 3 months (4.6 vs. 4.3 hours; P < .001), 12 (4 vs. 3.6 hours; P < .001) and 18 months (3.3 vs. 3.2 hours; P = .02). “Future research is needed to identify the optimal duration of behavioral interventions to sustain CPAP use long-term, and randomized trials in this area are needed,” the researchers wrote. Read more about